Skip to main content
Fig. 5 | Cancer Imaging

Fig. 5

From: Evaluating residual tumor after neoadjuvant chemotherapy for muscle-invasive urothelial bladder cancer: diagnostic performance and outcomes using biparametric vs. multiparametric MRI

Fig. 5

Sixty-four-year old woman with high grade muscle-invasive urothelial bladder cancer and small cell variant histology on transurethral resection. MRI performed after 4 cycles of neoadjuvant etoposide + cisplatin, showed minimal thickening on axial T2-weighted imaging at the site of resected tumor (A), no increased signal on axial diffusion-weighted imaging (B) but focal early nodular enhancement on sagittal post-contrast MRI (C). This was considered a negative biparametric and positive multiparametric MRI. At radical cystectomy, there was no residual tumor (ypT0). Patient was alive without recurrence at 1048 days after surgery

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us